MAHLY
Price
$18.34
Change
+$0.84 (+4.80%)
Updated
Sep 15 closing price
Capitalization
3.62B
SHPMF
Price
$1.53
Change
-$0.03 (-1.92%)
Updated
Aug 6 closing price
Capitalization
8.43B
Interact to see
Advertisement

MAHLY vs SHPMF

Header iconMAHLY vs SHPMF Comparison
Open Charts MAHLY vs SHPMFBanner chart's image
Medipal Holdings
Price$18.34
Change+$0.84 (+4.80%)
Volume$146
Capitalization3.62B
Shanghai Pharmaceuticals Holdings
Price$1.53
Change-$0.03 (-1.92%)
Volume$4.6K
Capitalization8.43B
MAHLY vs SHPMF Comparison Chart in %
Loading...
MAHLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SHPMF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MAHLY vs. SHPMF commentary
Sep 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MAHLY is a Buy and SHPMF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 29, 2025
Stock price -- (MAHLY: $18.34 vs. SHPMF: $1.53)
Brand notoriety: MAHLY and SHPMF are both not notable
Both companies represent the Medical Distributors industry
Current volume relative to the 65-day Moving Average: MAHLY: 44% vs. SHPMF: 123%
Market capitalization -- MAHLY: $3.62B vs. SHPMF: $8.43B
MAHLY [@Medical Distributors] is valued at $3.62B. SHPMF’s [@Medical Distributors] market capitalization is $8.43B. The market cap for tickers in the [@Medical Distributors] industry ranges from $94.6B to $0. The average market capitalization across the [@Medical Distributors] industry is $10.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MAHLY’s FA Score shows that 0 FA rating(s) are green whileSHPMF’s FA Score has 0 green FA rating(s).

  • MAHLY’s FA Score: 0 green, 5 red.
  • SHPMF’s FA Score: 0 green, 5 red.
According to our system of comparison, MAHLY is a better buy in the long-term than SHPMF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MAHLY’s TA Score shows that 3 TA indicator(s) are bullish while SHPMF’s TA Score has 2 bullish TA indicator(s).

  • MAHLY’s TA Score: 3 bullish, 2 bearish.
  • SHPMF’s TA Score: 2 bullish, 1 bearish.
According to our system of comparison, SHPMF is a better buy in the short-term than MAHLY.

Price Growth

MAHLY (@Medical Distributors) experienced а 0.00% price change this week, while SHPMF (@Medical Distributors) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Medical Distributors industry was +1.13%. For the same industry, the average monthly price growth was +3.16%, and the average quarterly price growth was +3.38%.

Industries' Descriptions

@Medical Distributors (+1.13% weekly)

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SHPMF($8.43B) has a higher market cap than MAHLY($3.62B). MAHLY has higher P/E ratio than SHPMF: MAHLY (14.12) vs SHPMF (6.65). MAHLY YTD gains are higher at: 14.090 vs. SHPMF (-6.707). MAHLY has higher annual earnings (EBITDA): 100B vs. SHPMF (14.2B). MAHLY has more cash in the bank: 251B vs. SHPMF (47.5B). MAHLY has higher revenues than SHPMF: MAHLY (3.6T) vs SHPMF (277B).
MAHLYSHPMFMAHLY / SHPMF
Capitalization3.62B8.43B43%
EBITDA100B14.2B704%
Gain YTD14.090-6.707-210%
P/E Ratio14.126.65212%
Revenue3.6T277B1,301%
Total Cash251B47.5B528%
Total DebtN/A55.2B-
FUNDAMENTALS RATINGS
MAHLY vs SHPMF: Fundamental Ratings
MAHLY
SHPMF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
67
Overvalued
PROFIT vs RISK RATING
1..100
87100
SMR RATING
1..100
5276
PRICE GROWTH RATING
1..100
4954
P/E GROWTH RATING
1..100
4562
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SHPMF's Valuation (67) in the null industry is in the same range as MAHLY (91). This means that SHPMF’s stock grew similarly to MAHLY’s over the last 12 months.

MAHLY's Profit vs Risk Rating (87) in the null industry is in the same range as SHPMF (100). This means that MAHLY’s stock grew similarly to SHPMF’s over the last 12 months.

MAHLY's SMR Rating (52) in the null industry is in the same range as SHPMF (76). This means that MAHLY’s stock grew similarly to SHPMF’s over the last 12 months.

MAHLY's Price Growth Rating (49) in the null industry is in the same range as SHPMF (54). This means that MAHLY’s stock grew similarly to SHPMF’s over the last 12 months.

MAHLY's P/E Growth Rating (45) in the null industry is in the same range as SHPMF (62). This means that MAHLY’s stock grew similarly to SHPMF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MAHLYSHPMF
RSI
ODDS (%)
Bearish Trend 3 days ago
59%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
39%
N/A
Momentum
ODDS (%)
Bullish Trend 3 days ago
44%
Bullish Trend 7 days ago
51%
MACD
ODDS (%)
Bullish Trend 3 days ago
28%
Bullish Trend 3 days ago
38%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
35%
Bullish Trend 3 days ago
39%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
35%
Bullish Trend 3 days ago
33%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bullish Trend 7 days ago
30%
Bearish Trend 3 days ago
52%
View a ticker or compare two or three
Interact to see
Advertisement
MAHLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SHPMF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
NZAC42.030.20
+0.47%
SPDR® MSCI ACWI Climate Paris AlignedETF
SIXD28.300.05
+0.18%
AllianzIM US Lrg Cp 6M Bfr10 Jun/Dec ETF
PDT13.250.02
+0.15%
John Hancock Premium Dividend Fund
VGLT56.56-0.07
-0.12%
Vanguard Long-Term Treasury ETF
EET74.70-0.43
-0.58%
ProShares Ultra MSCI Emerging Markets

MAHLY and

Correlation & Price change

A.I.dvisor tells us that MAHLY and MEPDF have been poorly correlated (+9% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MAHLY and MEPDF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MAHLY
1D Price
Change %
MAHLY100%
N/A
MEPDF - MAHLY
9%
Poorly correlated
N/A
ZYXI - MAHLY
5%
Poorly correlated
-1.36%
ARRJF - MAHLY
2%
Poorly correlated
N/A
SHPMF - MAHLY
2%
Poorly correlated
N/A
NSVGF - MAHLY
2%
Poorly correlated
N/A
More

SHPMF and

Correlation & Price change

A.I.dvisor tells us that SHPMF and MEPDF have been poorly correlated (+2% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SHPMF and MEPDF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SHPMF
1D Price
Change %
SHPMF100%
N/A
MEPDF - SHPMF
2%
Poorly correlated
N/A
MAHLY - SHPMF
2%
Poorly correlated
N/A
PDRX - SHPMF
1%
Poorly correlated
N/A
ZYXI - SHPMF
1%
Poorly correlated
-1.36%
AMFPF - SHPMF
-0%
Poorly correlated
N/A
More